Drug Type Small molecule drug |
Synonyms fucoidan |
Target |
Mechanism CLEC-2 agonists(C-type lectin domain family 1 member B agonists), CTNNB inhibitors(Beta catenins inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Helicobacter pylori infection | Phase 2 | CN | 01 Oct 2022 | |
Chronic Kidney Diseases | Preclinical | TW | 21 May 2015 | |
Renal fibrosis | Preclinical | TW | 21 May 2015 | |
Hemophilia | Preclinical | US | 16 Nov 2012 |
Not Applicable | 88 | fucodin | ljltepvpjj(lcsbbcjcgt): P-Value = 0.007 View more | Positive | 24 Jan 2023 | ||
placebo | |||||||
Not Applicable | - | gmqcictwpi(pqdsisdawh) = lskujrcuzx gjlltvullv (bhfgfvvbok ) | Positive | 21 Apr 2017 |